Announced Tue, 8 Sept · 14:13 IST
NCLT orders shareholder meeting for Venmax Hatri Pharma merger
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹15.58
prior close
₹14.38
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.5-6.2-0.5-3.7-4.4-4.7————
Up moveDown movePending
AI summary
NCLT Hyderabad on Sep 7, 2026 directed Venmax Drugs to hold an equity shareholders meeting on Oct 24, 2026 to consider the amalgamation of Hatri Pharma Private Limited into Venmax. Share exchange ratio is 1 Venmax share for every 1 Hatri Pharma share. Meetings of Hatri Pharma shareholders and all creditor meetings were dispensed with. Goal is a vertically integrated pharma business model.
Likely market impact
Venmax shareholders will vote on Oct 24, 2026. If approved, Hatri Pharma merges into the listed company, bringing vertical integration and operational synergies.